Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jonathan W, Uzorka"'
Autor:
Jonathan W. Uzorka, Lucia J.M. Kroft, Jaap A. Bakker, Erik W. van Zwet, Erik Huisman, Corine Prins, Cornelis J. van der Zwan, Tom H.M. Ottenhoff, Sandra M. Arend
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 15, Iss , Pp - (2019)
Background: Several radiological features have been reported in association with latent tuberculosis infection (LTBI) but it has not been studied which are specific. The aim of this study was to evaluate allegedly characteristic abnormalities on ches
Externí odkaz:
https://doaj.org/article/22b75d04dfe947259a781e3846385bb3
Autor:
Jonathan W, Uzorka, Jaap A, Bakker, Krista E, van Meijgaarden, Eliane M S, Leyten, Nathalie M, Delfos, David J, Hetem, Jos, Kerremans, Mieke, Zwarts, Sandra, Cozijn, Tom H M, Ottenhoff, Simone A, Joosten, Sandra M, Arend
Publikováno v:
The European respiratory journal. 60(2)
Screening for tuberculosis (TB) infection often includes QuantiFERON-TB Gold Plus (QFT) testing. Previous studies showed that two-thirds of patients with negative QFT results just below the cut-off, so-called borderline test results, nevertheless had
Autor:
Sandra M Arend, Jonathan W Uzorka
Publikováno v:
The Lancet Infectious Diseases. 22:164
Autor:
Tom H. M. Ottenhoff, Sandra M. Arend, Rajen S R S Ramai, Lucia J.M. Kroft, Jonathan W. Uzorka, Dinah L Duinkerk, Jaap A. Bakker
Publikováno v:
European Journal of Clinical Microbiology and Infectious Diseases, 39, 1329-1337. SPRINGER
European Journal of Clinical Microbiology & Infectious Diseases
European Journal of Clinical Microbiology & Infectious Diseases
Screening for latent tuberculosis infection (LTBI) is indicated before immunosuppressive therapies but is complicated by lack of a gold standard and limited by, e.g., immunosuppression. This study aimed to investigate a series of patients diagnosed w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a495737ed7f520c04464f5dd8c3ba73c
https://hdl.handle.net/1887/3181113
https://hdl.handle.net/1887/3181113
Publikováno v:
Open Forum Infectious Diseases
Open Forum Infectious Diseases, 6(7). OXFORD UNIV PRESS INC
Open Forum Infectious Diseases, 6(7). OXFORD UNIV PRESS INC
Objective Current guidelines recommend screening for latent tuberculosis infection (LTBI) with a tuberculin skin test (TST) or interferon gamma release assay (IGRA), or both. Many also recommend chest radiography (CXR), although its added value is un
Autor:
Erik Huisman, Sandra M. Arend, Cornelis J. van der Zwan, Jaap A. Bakker, Lucia J.M. Kroft, Erik W. van Zwet, Tom H. M. Ottenhoff, Jonathan W. Uzorka, Corine Prins
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 15, Iss, Pp-(2019)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 15. Elsevier
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 15. Elsevier
BackgroundSeveral radiological features have been reported in association with latent tuberculosis infection (LTBI) but it has not been studied which are specific. The aim of this study was to evaluate allegedly characteristic abnormalities on chest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a921ab1cfce6c530d9680d7acf29ab2
https://hdl.handle.net/1887/3195369
https://hdl.handle.net/1887/3195369
Autor:
Nathalie M. Delfos, Anne M.C. Witte, Jonathan W. Uzorka, Sandra M. Arend, Dick van Soolingen, Henk Scheper
Publikováno v:
European Respiratory Journal
European Respiratory Journal, 52(2)
European Respiratory Journal, 52(2)
Development of tuberculosis after a borderline QuantiFERON result during screening before TNF-α antagonist therapyhttp://ow.ly/zW1u30kw2Qv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c69baabcf6b12a5336cbff93bb80690
https://hdl.handle.net/1887/87143
https://hdl.handle.net/1887/87143
Autor:
Jonathan W. Uzorka, Sandra M. Arend, Willeke P. J. Franken, Ailko W. J. Bossink, Alida C. van Haeften, Eliane M. S. Leyten, Peter Boonstra, Tom H. M. Ottenhoff, Gert Doornenbal, Steven Thijsen
Publikováno v:
Tuberculosis, 111, 102-108
QuantiFERON (QFT) results near the cut-off are subject to debate. We aimed to investigate which borderline QFT results were due to Mycobacterium tuberculosis (Mtb)-specific responses or to test variability.In a contact investigation, tuberculin skin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49d89064a884b9c26d5c966a3ccf3933
https://hdl.handle.net/1887/75251
https://hdl.handle.net/1887/75251
Autor:
S. M. Arend, Jonathan W. Uzorka
Publikováno v:
The Lancet Infectious Diseases. 19:121-122
Autor:
Cornelis J. van der Zwan, Erik W. van Zwet, Corine Knetsch-Prins, Tom H. M. Ottenhoff, Sandra M. Arend, Jonathan W. Uzorka, Erik Huisman, Lucia J.M. Kroft, Jaap A. Bakker
Publikováno v:
European Respiratory Journal, 50(5)
Most borderline Quantiferon results are antigen-specific responses, defying the common assumption of random variation http://ow.ly/9a0X30fQBCO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66247f27d877749dde3e2d8d19882605
https://hdl.handle.net/1887/115053
https://hdl.handle.net/1887/115053